BRIEF-Shanghai Junshi Biosciences Responds to U.S. Suspending Its Coronavirus Treatment, Clarifying Media Report

SAYS U.S. FDA SUSPENDS ETESEVIMAB AND BAMLANIVIMAB ANTIBODY COCKTAIL TREATMENT FOR CORONAVIRUS, CLARIFYING MEDIA REPORT * SAYS FDA DID NOT REVOKE THE EMERGENCY USE AUTHORIZATION OF THE ANTIBODY …
( read original story …)